Literature DB >> 24787089

Who uses a prescription drug monitoring program and how? Insights from a statewide survey of Oregon clinicians.

Jessica M Irvine1, Sara E Hallvik2, Christi Hildebran2, Miguel Marino3, Todd Beran4, Richard A Deyo5.   

Abstract

UNLABELLED: Prescription drug monitoring programs (PDMPs) are relatively new but potentially useful tools to enhance prudent prescribing of controlled substances. However, little is known about the types of clinicians who make the most use of PDMPs, how these programs are incorporated into clinicians' work flow, or how clinicians and patients respond to the information. We therefore surveyed a random sample of Oregon providers, with 1,065 respondents. Clinicians in emergency medicine, primary care, and pain and addiction specialties were the largest number of registrants, but many frequent prescribers of controlled substances were not registered to use the PDMP. Among users, 95% reported accessing the PDMP when they suspected a patient of abuse or diversion, but fewer than half would check it for every new patient or every time they prescribe a controlled drug. Nearly all PDMP users reported that they discuss worrisome PDMP data with patients; 54% reported making mental health or substance abuse referrals, and 36% reported sometimes discharging patients from the practice. Clinicians reported frequent patient denial or anger and only occasional requests for help with drug dependence. More research is needed to optimize how clinicians use PDMPs across settings and how clinicians and patients respond to the data. PERSPECTIVE: This study examined differences between PDMP users and nonusers and how clinicians in various specialties use PDMPs in practice. A better understanding of effective PDMP use will facilitate access to treatment for patients with pain while curbing the prescription drug epidemic and may ultimately reduce abuse, misuse, and overdose death.
Copyright © 2014 American Pain Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Prescription drug monitoring program; controlled substances; opioid prescribing; prescription drug abuse; survey

Mesh:

Substances:

Year:  2014        PMID: 24787089      PMCID: PMC4079731          DOI: 10.1016/j.jpain.2014.04.003

Source DB:  PubMed          Journal:  J Pain        ISSN: 1526-5900            Impact factor:   5.820


  12 in total

1.  Reported response rates to mailed physician questionnaires.

Authors:  S M Cummings; L A Savitz; T R Konrad
Journal:  Health Serv Res       Date:  2001-02       Impact factor: 3.402

2.  Doctor and pharmacy shopping for controlled substances.

Authors:  Gretchen L Peirce; Michael J Smith; Marie A Abate; Joel Halverson
Journal:  Med Care       Date:  2012-06       Impact factor: 2.983

3.  Influencing controlled substance prescribing: attending and resident physician use of a state prescription monitoring program.

Authors:  Lance Feldman; Kristi Skeel Williams; Michele Knox; John Coates
Journal:  Pain Med       Date:  2012-06-08       Impact factor: 3.750

4.  Pain management by primary care physicians, pain physicians, chiropractors, and acupuncturists: a national survey.

Authors:  Brenda Breuer; Ricardo Cruciani; Russell K Portenoy
Journal:  South Med J       Date:  2010-08       Impact factor: 0.954

5.  How does use of a prescription monitoring program change medical practice?

Authors:  Traci C Green; Marita R Mann; Sarah E Bowman; Nickolas Zaller; Xaviel Soto; John Gadea; Catherine Cordy; Patrick Kelly; Peter D Friedmann
Journal:  Pain Med       Date:  2012-07-30       Impact factor: 3.750

6.  Response rates to mail surveys published in medical journals.

Authors:  D A Asch; M K Jedrziewski; N A Christakis
Journal:  J Clin Epidemiol       Date:  1997-10       Impact factor: 6.437

7.  Characteristics of opioid prescriptions in 2009.

Authors:  Nora D Volkow; Thomas A McLellan; Jessica H Cotto; Meena Karithanom; Susan R B Weiss
Journal:  JAMA       Date:  2011-04-06       Impact factor: 56.272

8.  A history of being prescribed controlled substances and risk of drug overdose death.

Authors:  Leonard J Paulozzi; Edwin M Kilbourne; Nina G Shah; Kurt B Nolte; Hema A Desai; Michael G Landen; William Harvey; Larry D Loring
Journal:  Pain Med       Date:  2011-10-25       Impact factor: 3.750

9.  A statewide prescription monitoring program affects emergency department prescribing behaviors.

Authors:  David F Baehren; Catherine A Marco; Danna E Droz; Sameer Sinha; E Megan Callan; Peter Akpunonu
Journal:  Ann Emerg Med       Date:  2010-01-04       Impact factor: 5.721

10.  Clinician impression versus prescription drug monitoring program criteria in the assessment of drug-seeking behavior in the emergency department.

Authors:  Scott G Weiner; Christopher A Griggs; Patricia M Mitchell; Breanne K Langlois; Franklin D Friedman; Rebecca L Moore; Shuo Cheng Lin; Kerrie P Nelson; James A Feldman
Journal:  Ann Emerg Med       Date:  2013-07-09       Impact factor: 5.721

View more
  28 in total

1.  Factors Influencing Judgments to Consult Prescription Monitoring Programs: A Factorial Survey Experiment.

Authors:  Matthew J Witry; Barbara J St Marie; Brahmendra Reddy Viyyuri; Paul D Windschitl
Journal:  Pain Manag Nurs       Date:  2019-05-24       Impact factor: 1.929

2.  Prescription Drug Monitoring Program Use: National Dental PBRN Results.

Authors:  J L McCauley; G H Gilbert; D L Cochran; V V Gordan; R S Leite; R B Fillingim; K T Brady
Journal:  JDR Clin Trans Res       Date:  2018-10-29

3.  How, why, and for whom do emergency medicine providers use prescription drug monitoring programs?

Authors:  Robert J Smith; Austin S Kilaru; Jeanmarie Perrone; Breah Paciotti; Frances K Barg; Sarah M Gadsden; Zachary F Meisel
Journal:  Pain Med       Date:  2015-02-17       Impact factor: 3.750

4.  Physician Time Burden Associated with Querying Prescription Drug Monitoring Programs.

Authors:  Marcus A Bachhuber; Brendan Saloner; Marc LaRochelle; Jessica S Merlin; Brandon C Maughan; Dan Polsky; Naum Shaparin; Sean M Murphy
Journal:  Pain Med       Date:  2018-10-01       Impact factor: 3.750

Review 5.  Provider perceptions of system-level opioid prescribing and addiction treatment policies.

Authors:  Rebecca L Haffajee; Cecelia A French
Journal:  Curr Opin Psychol       Date:  2019-02-04

6.  Clinicians' Use of Prescription Drug Monitoring Programs in Clinical Practice and Decision-Making.

Authors:  Gillian J Leichtling; Jessica M Irvine; Christi Hildebran; Deborah J Cohen; Sara E Hallvik; Richard A Deyo
Journal:  Pain Med       Date:  2017-06-01       Impact factor: 3.750

7.  Physicians' Perspectives Regarding Prescription Drug Monitoring Program Use Within the Department of Veterans Affairs: a Multi-State Qualitative Study.

Authors:  Thomas R Radomski; Felicia R Bixler; Susan L Zickmund; KatieLynn M Roman; Carolyn T Thorpe; Jennifer A Hale; Florentina E Sileanu; Leslie R M Hausmann; Joshua M Thorpe; Katie J Suda; Kevin T Stroupe; Adam J Gordon; Chester B Good; Michael J Fine; Walid F Gellad
Journal:  J Gen Intern Med       Date:  2018-03-08       Impact factor: 5.128

8.  Development and Feasibility of an Academic Detailing Intervention to Improve Prescription Drug Monitoring Program Use Among Physicians.

Authors:  Kelly S Barth; Sarah Ball; Rachel S Adams; Ruslan Nikitin; Nikki R Wooten; Zaina P Qureshi; Mary J Larson
Journal:  J Contin Educ Health Prof       Date:  2017       Impact factor: 1.355

9.  Assessing The Impact Of State Policies For Prescription Drug Monitoring Programs On High-Risk Opioid Prescriptions.

Authors:  Yuhua Bao; Katherine Wen; Phyllis Johnson; Philip J Jeng; Zachary F Meisel; Bruce R Schackman
Journal:  Health Aff (Millwood)       Date:  2018-10       Impact factor: 6.301

10.  How the presentation of patient information and decision-support advisories influences opioid prescribing behavior: A simulation study.

Authors:  Mustafa I Hussain; Ariana M Nelson; Brent G Yeung; Lauren Sukumar; Kai Zheng
Journal:  J Am Med Inform Assoc       Date:  2020-04-01       Impact factor: 4.497

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.